References
- 1. Saleh G, Evans HL, Ro JY, Ayala AG. Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow up. Cancer 1992; 70: 2827-30.
- 2. Meis-Kindblom JM, Bergh P, Guntergerg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999; 23: 636-50.
- 3. Mendez-Probst CE, Erdeljan P, Castonguay M, Gabril M, Wehrli B, Razvi H. Myxoid chondrosarcoma of the scrotum: a case report and review of literature. Can Urol Assoc J 2010; 4: (E)109-11.
- 4. Gebhardt MC, Parekh SG, Rosenberg AE, Rosenthal DI. Extraskeletal myxoid chondrosarcoma of the knee. Skeletal Radiol 1999; 28: 354-8.
- 5. Okamoto S, Hara K, Sumita S, Sato K, Hisaoka M, Aoki T, et al. Extraskeletal myxoid chondrosarcoma arising in the finger. Skeletal Radiol 2002; 31: 296-300.
- 6. Tateishi U, Hasegawa T, Nojima T, Takegami T, Arai Y. MRI features of extraskeletal myxoid chondrosarcoma. Skeletal Radiol 2006; 35: 27-33.
- 7. Hirabayashi Y, Ishida T, Yoshida MA, Kojima T, Ebihara Y, Machinami R, et al. Translocation (9;22)(q22;q12). Recurrent chromosome abnormality in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 1995; 81: 33-7.
- 8. Orndal C, Carlen B, Akerman M, Willén H, Mandahl N, Heim S, et al. Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry and DNA flow cytometry. Cytopathology 1991; 2: 261-70.
- 9. Sciot R, Dal Cin P, Fletcher C, Samson I, Smith M, De Vos R, et al. t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod Pathol 1995; 8: 765-8.
- 10. Stenman G, Andersson H, Mandahl N, Meis-Kindblom JM, Kindblom LG. Translocation t(9;22)(q22;q12) is a primary cytogenetic abnormality in extraskeletal myxoid chondrosarcoma. Int J Cancer 1995; 62: 398-402.
- 11. Turc-Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 1988; 30: 145-50.
- 12. Rubin BP, Fletcher JA. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors? Adv Anat Pathol 1999; 6: 204-12.
- 13. Kawaguchi S, Wada T, Nagoya S, Ikeda T, Isu K, Yamashiro K, et al. Extraskeletal myxoid chondrosarcoma: a multi-institute study of 42 cases in Japan. Cancer 2003; 97: 1285-92.
- 14. Kondo T, Yamada K, Noda K, Nakayama H, Kameda Y. Radiologic-prognostic correlation in patients with small pulmonary adenocarcinoma. Lung C ancer 2002; 36: 49-57.
- 15. Saito H, Kameda Y, Masui K, Murakami S, Kondo T, Ito H, et al. Correlation between thin-section findings, histopathological and clinical findings of small pulmonary adenocarcinomas. Lung Cancer 2011; 71: 137-43.
- 16. Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mod Imaging 2004; 31: 189-95.